While SMARCAL1 loss-of-function mutations in telomerase-negative Glioma cells promote selective telomere lengthening and carcinogenesis, its precise function in pan-cancer malignancies is still unknown and has to be clarified41. This evidence concerns the gene SMARCAL1 and central nervous system cancer.